
    
      Patients were diagnosed with pulmonary arterial hypertension according to the Task Force for
      the Diagnosis and Treatment of Pulmonary Hypertension of f the European Society of Cardiology
      (ESC) and European Respiratory Society (ERS). Primary outcome measurement was exercise
      capacity, secondary outcomes were respiratory and peripheral muscle strength, physical
      activity, quality of life, fatigue, dyspnea and depression.
    
  